Imaging News and Research

RSS

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has been awarded a grant of $304,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The grant is to fund a project entitled: “Development of an alpha6*-selective Neuronal Nicotinic Receptor (NNR) Imaging Agent as a Parkinson’s Disease Biomarker” and is the second awarded to Targacept by MJFF in the last six months.

9 Feb 2010

Doctors do not follow evidence-based guidelines for treating low back pain, says report

Australian general practitioners often treat patients with low back pain in a manner that does not appear to match the care endorsed by international clinical guidelines, according to a report in the February 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

9 Feb 2010

ebrary introduces new subscription database in Medical Technology

Health care companies that design and manufacture medical devices, equipment, and instruments can now help their technologists, engineers, and other employees conduct research more efficiently and effectively, resulting in greater cost savings and faster development times for new products.

9 Feb 2010

Study reveals people with anorexia nervosa have increased fat content in their bone marrow

People with anorexia nervosa, paradoxically, have strikingly high levels of fat within their bone marrow, report researchers at Children's Hospital Boston. Their findings, based on MRI imaging of the knees of 20 girls with anorexia and 20 healthy girls of the same age, appear in the February issue of the Journal of Bone and Mineral Research.

9 Feb 2010

Sirona Dental Systems announces first-quarter fiscal 2010 results

Sirona, the dental technology leader, today announced its financial results for the quarter ended December 31, 2009.

8 Feb 2010

Third-quarter fiscal 2010 results announced by Chindex International

Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the third quarter and first nine months of fiscal year 2010.

8 Feb 2010

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

MDS Nordion, a global leader in providing products and services for medical imaging and radiotherapeutics, today announced that two of the largest health insurers in the United States have recently approved coverage of radioembolization to treat unresectable liver cancer, which includes the use of MDS Nordion's TheraSphere(R) treatment. The two insurance companies and their affiliates together serve more than one-quarter of Americans and do business in all 50 states.

6 Feb 2010

AMAG Pharmaceuticals releases safety update on Feraheme Injection

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® (ferumoxytol) Injection for intravenous use.

6 Feb 2010

Local organizations team up to support Haiti's healthcare system

Injured Haitians desperately in need of medical treatment will soon have advanced technology available to the medical professionals providing their care. Through a partnership of Stamford Hospital, FUJIFILM Medical Systems USA (Fujifilm), and AmeriCares, a portable digital x-ray system is being donated to the Haitian relief effort and will be sent to a hospital where currently x-ray capabilities are simply non-existent.

6 Feb 2010

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

5 Feb 2010

Nearly 50% of essential services provided for cancer treatment not reimbursed by Medicare

A comprehensive study of the components of the delivery of modern-day cancer care in community oncology practices revealed that Medicare covers only 56% of the actual costs of administering chemotherapy and providing related infusion room services to seniors with cancer. The remaining costs -- for essential services provided such as treatment planning, care coordination, and follow-up care planning -- are not reimbursed by Medicare, causing many oncology practices to struggle to continue to provide care under the Medicare program.

5 Feb 2010

Non-invasive MR Spectroscopy to determine ability to be fathers

Men with no sperm in their ejaculate—a condition known as azoospermia—may no longer need invasive procedures to determine if they have sperm in their testes according to a new study published in Human Reproduction.

5 Feb 2010

FDA awards highest quality rating for Carol Milgard Breast Center

The Carol Milgard Breast Center was awarded the highest quality review possible by the Food and Drug Administration (FDA) for adhering to the most rigorous quality and safety standards set forth by the Mammography Quality Standards Act (MQSA).

5 Feb 2010

Vanderbilt Heart and Vascular Institute offers new blood test to predict heart disease

Just in time for American Heart Month, Vanderbilt Heart and Vascular Institute is offering a new blood test that can predict if a patient is at high risk for heart disease. Vanderbilt is among the first institutions in the country, and the only one in Tennessee, to offer this test.

5 Feb 2010

Michael J. Fox Foundation announces more than $2.8M in awards to discover biomarkers of PD

The Michael J. Fox Foundation for Parkinson's Research today announced more than $2.8 million in awards for 13 new projects to speed the discovery of biomarkers of PD.

4 Feb 2010

IMRIS to acquire NASL

IMRIS Inc. today announced that it has entered into a definitive agreement to acquire NeuroArm Surgical Limited ("NASL"), a privately held company based in Calgary, Alberta, and its magnetic resonance-compatible neurosurgical robot. The companies expect to close the transaction no later than February 8, 2010, subject to the satisfaction of customary closing conditions. IMRIS has also entered into a memorandum of understanding with MacDonald Dettwiler and Associates Limited ("MDA") to create the next generation of the technology.

4 Feb 2010

Toshiba America Medical Systems' Viamo laptop ultrasound system receives FDA clearance

Designed to meet the needs of today’s hospitals by combining portability with high-end radiology features, Toshiba America Medical Systems, Inc.’s new ViamoTM laptop ultrasound system has received FDA clearance.

4 Feb 2010

ASTRO leads the way to help physicians improve safety and reduce medical errors

The American Society for Radiation Oncology has committed to a six-point patient protection plan that will improve safety and quality and reduce the chances of medical errors, ASTRO Board Chairman Tim R. Williams, M.D., said today.

4 Feb 2010

Amantadine binds to and blocks critical M2 proton channel necessary for influenza virus to infect healthy cells

Antiviral drugs block influenza A viruses from reproducing and spreading by attaching to a site within a proton channel necessary for the virus to infect healthy cells, according to a research project led by Iowa State University's Mei Hong and published in the Feb. 4 issue of the journal Nature.

4 Feb 2010

Molecular Devices brand re-launched into life sciences marketplace

Today, Molecular Devices, Inc.—now part of Danaher Corporation—re-launched the Molecular Devices brand into the life sciences marketplace. The renewed corporate brand is focused primarily on meeting customer needs and exceeding customer expectations, and includes an evolved visual identity system.

From Danaher 4 Feb 2010

Imaging News and Research

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Doctors do not follow evidence-based guidelines for treating low back pain, says report

ebrary introduces new subscription database in Medical Technology

Study reveals people with anorexia nervosa have increased fat content in their bone marrow

Sirona Dental Systems announces first-quarter fiscal 2010 results

Third-quarter fiscal 2010 results announced by Chindex International

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

AMAG Pharmaceuticals releases safety update on Feraheme Injection

Local organizations team up to support Haiti's healthcare system

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Nearly 50% of essential services provided for cancer treatment not reimbursed by Medicare

Non-invasive MR Spectroscopy to determine ability to be fathers

FDA awards highest quality rating for Carol Milgard Breast Center

Vanderbilt Heart and Vascular Institute offers new blood test to predict heart disease

Michael J. Fox Foundation announces more than $2.8M in awards to discover biomarkers of PD

IMRIS to acquire NASL

Toshiba America Medical Systems' Viamo laptop ultrasound system receives FDA clearance

ASTRO leads the way to help physicians improve safety and reduce medical errors

Amantadine binds to and blocks critical M2 proton channel necessary for influenza virus to infect healthy cells

Molecular Devices brand re-launched into life sciences marketplace

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News